0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hematologic Malignancies Testing"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Hematologic Malignancies Testing Global Market Report 2025 - Product Thumbnail Image

Hematologic Malignancies Testing Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$3,400USDGBP
EUR$4,000USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
  • 7 Results (Page 1 of 1)
Loading Indicator

The Hematologic Malignancies Testing market is a subset of the Diagnostics industry, focusing on the detection and diagnosis of blood-related cancers. Tests are used to detect the presence of cancerous cells in the blood, bone marrow, and lymph nodes. These tests can also be used to monitor the progression of the disease and to determine the best course of treatment. Common tests include flow cytometry, immunophenotyping, and cytogenetic analysis. The Hematologic Malignancies Testing market is highly competitive, with a range of companies offering tests and services. These include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, and Roche Diagnostics. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more